Podchaser Logo
Home
STEP HFpEF DM and Fair Allocation of Incretin-Based Therapies

STEP HFpEF DM and Fair Allocation of Incretin-Based Therapies

Released Saturday, 20th April 2024
Good episode? Give it some love!
STEP HFpEF DM and Fair Allocation of Incretin-Based Therapies

STEP HFpEF DM and Fair Allocation of Incretin-Based Therapies

STEP HFpEF DM and Fair Allocation of Incretin-Based Therapies

STEP HFpEF DM and Fair Allocation of Incretin-Based Therapies

Saturday, 20th April 2024
Good episode? Give it some love!
Rate Episode

In this episode, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, tackle a pair of related topics: what the STEP HFpEF DM trial from ACC.24 means for the diabetes community and the need for fair and equitable allocation of incretin-based therapies in the face of ongoing drug shortages and overwhelming demand.

Show More

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features